• Led and managed a team of 15 Directors, Senior Scientists, Scientists and Technical Laboratory Staff• Key member of the Sanofi Pasteur VaxDesign (SPV) Management Leadership Team through which steered campus objectives, operations, and involvement in research projects. • Project Lead for multiple critical Sanofi projects including Dengue, New Pertussis, RSV, and MenB.o Directed campus involvement in these Sanofi Pasteur projectso Guide SPV’s Project Leaders and efforts to evaluate innate, humoral, and cellular immune responses to novel vaccine candidates and antigenso Developed strategy and project mapping to guide pre-clinical candidates to the clinic and regu-latory acceptance• Global Project Team Member and Translational Sub-Team Lead for the development of an RSV vaccine for the elderly population.o Identifying, developing, and directing the evaluation of several strategies aimed at establishing correlate of protection and immunological biomarkerso Generating pre-clinical data to guide selection of vaccine candidate selection for clinical trial and regulatory acceptance for clinical trial• Implemented the structure at Sanofi Pasteur VaxDesign for clinical sample testing for immunological Translational Research.o Accomplished the incorporation sample and document management, training records, and data integrity measures that passed internal assessment standards

• Led and managed a team of 15 Directors, Senior Scientists, Scientists and Technical Laboratory Staff• Key member of the Sanofi Pasteur VaxDesign (SPV) Management Leadership Team through which steered campus objectives, operations, and involvement in research projects. • Project Lead for multiple critical Sanofi projects including Dengue, New Pertussis, RSV, and MenB.o Directed campus involvement in these Sanofi Pasteur projectso Guide SPV’s Project Leaders and efforts to evaluate innate, humoral, and cellular immune responses to novel vaccine candidates and antigenso Developed strategy and project mapping to guide pre-clinical candidates to the clinic and regu-latory acceptance• Global Project Team Member and Translational Sub-Team Lead for the development of an RSV vaccine for the elderly population.o Identifying, developing, and directing the evaluation of several strategies aimed at establishing correlate of protection and immunological biomarkerso Generating pre-clinical data to guide selection of vaccine candidate selection for clinical trial and regulatory acceptance for clinical trial• Implemented the structure at Sanofi Pasteur VaxDesign for clinical sample testing for immunological Translational Research.o Accomplished the incorporation sample and document management, training records, and data integrity measures that passed internal assessment standards

• Managed a team of 4-7 Scientists and Technical Laboratory Staff.• Global Project Team Member for Sanofi's flagship CYD tetravalent vaccine and the next generation Dengue vaccine.o Led implementation of assays to further interrogate the immunogenicity response to Sanofi Pasteur's CYD tetravalent vaccine following Phase III clinical study results: Serotype-specific antibody depletion and neutralization assays Antibody affinity testing using Bio-Layer Interferometry• Contributed to the preparation of documents for 2 FDA Type C meetings to review the human in vitro biomimetic module platform named MIMIC System.• Planned and led investigations to evaluate the precision and reproducibility of the MIMIC System and comparisons to human in vivo immune responses following vaccination.

• Fronted the development of the MIMIC System B cell module capable of evaluating in vitro human antigen-specific recall and naive B cells responses.• Contributed to the development of the full MIMIC System, a human biomimetic in vitro model that interrogates human innate, humoral, and cellular immunity.o The MIMIC System is now routinely being used across Sanofi Pasteur's R&D platform and the Department of Defense for vaccine candidate pre-clinical testing